America's Uranium Crisis = A Massive Opportunity

Ninety percent of America's uranium is imported. With the US scrambling to rebuild domestic supply, Canadian uranium companies are in prime position. One small-cap stock could be set to benefit.

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Eaton's Growth Targets Look Achievable, Analyst Raises EPS Forecast For 2026 & 2027

Analyst reaffirms Buy rating on Eaton with $410 price target after investor day. Expects strong growth in data centers, commercial, utilities, and aerospace.

India and New Zealand look to bolster ties after reviving free trade talks

NEW DELHI (AP) — Indian Prime Minister Narendra Modi and his New Zealand counterpart, Christopher Luxon, met Monday seeking to deepen their defense and economic ties, a day after the countries announced the revival of negotiations for a free trade agreement.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

Goldman Sachs Analyst Anticipates Clarity On Vertex's Investment Roadmap And Product Monetization At Investor Day

Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates Buy rating with $48 price target.

Intel Shares Surge As New CEO Plans Major Overhaul: What's Going On?

Intel Corporation (NASDAQ: INTC) shares are trading higher Monday following reports that incoming CEO Lip-Bu Tan is preparing a sweeping overhaul of the company's chip design, manufacturing operations and AI strategy.

The Gold Shift No One's Talking About - Yet - Ad

Massive gold shipments are quietly moving from London to the U.S.--no headlines, no explanations. Could a full-scale audit or a new gold-backed system be coming? Smart money isn't waiting. My gold strategy is already doubling physical gold's returns this year.

NBA Legend Shaq's Walmart Shopping Spree Ends In Credit Card Decline - Here's How Much He Tried To Spend

Basketball superstar Shaquille O'Neal's impact goes beyond basketball, with his larger-than-life personality and smart investments. Yet, one of his most unforgettable moments happened at Walmart.

Law firm sues over Trump executive order that seeks to suspend security clearances

WASHINGTON (AP) — A during the 2016 presidential campaign sued the federal government Tuesday over an executive order that seeks to strip its attorneys of security clearances.

Man Who Predicted 2008 Crash Issues Dire Warning: "Get Out of Stocks Now" - Ad

Tech stocks are tanking--Nvidia down 30%, Tesla 50%--and ex-Wall Street CEO Dylan Jovine says it's about to get worse. He predicted the 2008 crash & made 700% gains while the market collapsed. Now, he's moving millions into a billionaire safe haven--and revealing his 4-step strategy. Don't wait!

What makes Greenland a strategic prize at a time of rising tensions? And why now?

NUUK, Greenland (AP) — When U.S. President Donald Trump first suggested in 2019, people thought it was just a joke. No one is laughing now.

New Study: 50 Stocks Will Crash While 7 MAGA Stocks Will Soar - Ad

If you own any of these stocks -- directly or through mutual funds -- I want to encourage you to sell them before April 30th. I've compiled all 50 companies in my "MAGA Blacklist" report. Your retirement could depend on seeing this list.

Warren Buffett on Debt and Donald Trump's Money Moves: Trump 'Never Went Right'

In a piece of advice that continues to hold relevance, investor Warren Buffett once warned students about the perils of excessive borrowing, citing Donald Trump as a case in point.

This 'Dune' isn't fiction. It's the longest conveyer belt in the US and moving sand in Texas

KERMIT, Texas (AP) — It's longer than the width of Rhode Island, snakes across the oil fields of the southwest U.S. and crawls at 10 mph – too slow for a truck and too long for a train.

Stocks to Crash on March 16, 2026? Here's Compelling Reason Why - Ad

Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.

Apple's AR Glasses Approach Aside, Google Makes Its Move On Eye-Tracking Tech With $115 Million AdHawk Acquisition: Report

As Apple reportedly reconsiders its AR glasses strategy, Google is moving forward with a $115 million acquisition of eye-tracking startup AdHawk to bolster its next-gen smart glasses efforts.

South Africa plans to spend more on health and defense after the US cuts aid

JOHANNESBURG (AP) — Lawmakers in South Africa laid out plans to shore up the budgets for health and defense but also put up value added tax by 0.5%, a move that will raise the cost of living as consumers pay more for goods, including food, and services.

AI + Smart Glass = A Nasdaq Sleeper - Ad

This recent Nasdaq IPO is quietly making waves, thanks to its 95% market share in a $240M aerospace niche. With patented technology that integrates AI into smart glass, this company is poised for massive growth as the market races toward $124 billion by 2029.

The "Second Wave" of 2025 Crashes (Could Be Worst in Us History) - Ad

According to the man who predicted 2008, 2020, and 2022... A new wave of crashes are coming to the US stock market. But these will be different. The moment they hit, they could kick off the worst (and longest) financial crisis in American history.

Melinda French Gates Reveals An IBM Manager Inspired Her To Join Bill Gates Co-Founded 'Little Company' Microsoft

Melinda French Gates credited a conversation with an IBM (NYSE: IBM) hiring manager for her decision to join Microsoft (NASDAQ: MSFT), a choice that significantly impacted her career and personal life.

Exposed: 3 Cent Crypto to Explode March 24th? - Ad

Chris Rowe, the man who spotted 44 different coins that have returned over 100%, is now making the biggest crypto call of his ENTIRE career.... Because a powerful crypto event will trigger on March 24th... Sending hundreds of tiny cryptos soaring 5X, 50X, even 100X -- in just days.

A government program made tax filing free and more efficient. Musk and DOGE may get rid of it anyway

WASHINGTON (AP) — Mia Francis, a 22-year-old barista from Boston, filed her taxes on her own this year for the first time, using a free government tax filing program that made it easy because it did most of the work for her.

Millionaire Trader: "My No. 1 Stock of the Decade" (Revealed Free) - Ad

The stock revealed right here just may be millionaire trader Jeff Clark's favorite stock ever. Because this one stock alone has been responsible for some of the biggest gains he's ever handed my readers... 195% in under a month... 85% in 14 days... 176% in 5 weeks... 120% in under 3 months... 55% in two days... 138% in 8 days... And even 222% in 8 days.

Critics warn staff cuts at federal agencies overseeing US dams could put public safety at risk

COULEE DAM, Wash. (AP) — Trump administration workforce cuts at federal agencies overseeing U.S. dams are threatening their ability to provide reliable electricity, supply farmers with water and protect communities from floods, employees and industry experts warn.

The Billionaire Bet That Could Change Uranium Forever - Ad

The world's richest investors--Gates, Bezos, Altman--are pouring billions into nuclear energy. With uranium demand surging, one tiny uranium junior could potentially be the next big winner.

Tesla Out, Ford In: City Of Baltimore Goes 'In A Different Direction' Reversing EV Deal From 2024

Tesla is losing an EV city fleet deal in Baltimore to Ford. A look at what happened and how politics may have factored into the decision.

What's Going On With Gap Stock Friday?

Gap stock is trading higher on Friday after the company reported fourth-quarter earnings on Thursday after the market closed.

Warning: China Launches AI Attack on America - Ad

China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.

What to know about Yemen's Houthi rebels as the US steps up attacks on Iran-backed group

DUBAI, United Arab Emirates (AP) — The United States under has launched a new campaign of intense airstrikes targeting .

Intel Beats Investor Lawsuit After $32 Billion Stock Plunge - Judge Rules Foundry Losses Weren't Misleading

Intel secured a legal victory after a U.S. judge dismissed a shareholder lawsuit alleging the company misled investors about foundry losses, which contributed to a $32 billion stock plunge.

UEC Soared 2,500 Percent--Could This Uranium Junior Be Next? - Ad

Five years ago, UEC was a tiny uranium stock. Now, it's a $3.11 billion powerhouse. This small uranium junior is sitting on prime assets and could be next.

Japan's Seven & i sells retail business to Bain Capital for $5.4 billion, plans IPO

Japan’s Seven & i, the parent company of the Japanese 7-Eleven convenience store chain, said Thursday it is selling its supermarket store assets to Bain Capital for about $5.4 billion.

Trump Says He Was 'Little Bit Sarcastic' When He Said He Would End The Russia-Ukraine War In A Day: 'What I Really Mean Is...'

On Sunday, President Donald Trump addressed his earlier claim of resolving the Ukraine-Russia conflict within 24 hours, clarifying that his statement was “a little bit sarcastic.”

Trump, Musk & the Gold Play No One Sees Coming - Ad

Fort Knox mystery could send gold skyrocketing. Because the real danger isn't missing gold. It's decades of Fed manipulation collapsing overnight. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding.

Georgia lawmakers push to ban automated speed cameras near schools

DECATUR, Ga. (AP) — Outside Beacon Hill Middle School in the Atlanta suburb of Decatur, like along hundreds of roadsides across Georgia, the unblinking eye of a camera tickets drivers who speed through a school zone.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service